Status
Conditions
Treatments
About
The goal of this clinical trial is to compare stepped care to stratified care as overall healthcare models for children and adolescents aged 8-17 with anxiety disorders. It addresses one main question:
• Is stepped care non-inferior to stratified care in supporting participants to achieve a treatment response?
Researchers will compare two care models:
Participants will:
Full description
A detailed description is available in the full study protocol. All study protocol versions can be accessed at the Open Science Framework (https://osf.io/a9qhw/).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Confirmed by the child and/or caregiver. 2) Principal DSM-5-TR anxiety disorder of social anxiety disorder, generalized anxiety disorder, panic disorder, separation anxiety disorder, specific phobia, or agoraphobia.
Confirmed by the structured diagnostic interview (DIAMOND-KID). "Principal" indicates that the anxiety disorder is judged by the clinician to be in most urgent need of treatment (among potential co-occurring disorders).
Confirmed by the caregiver. 4) Child and at least one caregiver can read, write, and communicate in Swedish.
Confirmed by the child and/or caregiver. 5) Child (≤13 years) and caregiver have access to a Swedish electronic identification (BankID or Freja eID).
Confirmed by the child and/or caregiver. 7) Ability to attend in-person CBT sessions at the clinic.
Confirmed by the child and/or caregiver.
Exclusion criteria
Confirmed by a specific phobia of this sort being classified as the most functionally impairing anxiety disorder during the structured diagnostic interview (DIAMOND-KID).
Confirmed by the child and/or caregiver. 3) Social/familial/educational difficulties in more immediate need of management than an anxiety disorder.
Confirmed by the assessor through information from the child and/or caregiver and/or other available sources.
Confirmed by the assessor through information from the child and/or caregiver and other available sources.
Confirmed by the assessor through information from the caregiver and other available sources.
Primary purpose
Allocation
Interventional model
Masking
556 participants in 2 patient groups
Loading...
Central trial contact
Eva Serlachius, MD, PhD; Matti Cervin, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal